rhodamine 123 has been researched along with Benign Neoplasms in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (14.71) | 18.7374 |
1990's | 6 (17.65) | 18.2507 |
2000's | 8 (23.53) | 29.6817 |
2010's | 12 (35.29) | 24.3611 |
2020's | 3 (8.82) | 2.80 |
Authors | Studies |
---|---|
Kim, HS; Lee, JS; Park, JH; Sharma, S; Shin, JK; Yoon, S | 1 |
Bhattarai, N; Chen, M; L Pérez, R; M Strongin, R; M Warner, I; McDonough, K; Ravula, S | 1 |
Edaki, K; Kamioka, H; Kasahara, H; Ogihara, T; Tomono, T; Yano, K | 1 |
Chen, Y; Huang, J; Li, Y; Liu, F; Liu, X; Ma, Y; Wang, T; Wang, Z; Zhang, H; Zhang, X | 1 |
Cui, C; Fu, L; Ge, C; Song, X; Su, X; To, KKW; Wang, F; Wang, X; Zhang, H | 1 |
Fu, Q; Liu, F; Racette, K; Ramishetti, S; Tang, J; Wang, D; Wang, Y | 1 |
Balkay, L; Goda, K; Krasznai, Z; Krasznai, ZT; Márián, T; Mikecz, P; Nizsalóczki, E; Szabó, JP; Szalóki, G; Trencsényi, G | 1 |
Gorbenko, AS; Olkhovskii, IA | 1 |
Chen, S; Li, X; Liu, M; Shi, Q; Xu, X; Zhang, J; Zhang, L; Zhang, X | 1 |
Hong, S; Li, Y; Shen, H; Wang, D; Wang, J; Wang, Y; Xiao, Q; Xie, B; Zhang, Q; Zhang, X | 1 |
Evans, BR; Liu, CG; Liu, X; Medina, DJ; Wu, H; Yang, JM; Zhu, H | 1 |
Kurtoglu, M; Lampidis, TJ | 1 |
Bacsó, Z; Goda, K; Szabó, G | 1 |
Carey, JR; Chen, CY; Chen, JS; Ke, JH; Lin, JJ; Wang, LF | 1 |
Belostotsky, I; da Silva, SM; Indig, GL; Paez, MG | 1 |
Ashokan, A; Chandran, P; Koyakutty, M; Menon, D; Nair, S; Sasidharan, A | 1 |
Cheng, C; Fu, LW; Huang, HB; Liang, YJ; To, KK; Wang, F; Wang, XK; Zhang, X; Zhou, W; Zhou, WJ | 1 |
Chang, GQ; Gao, W; Jin, WN; Li, HW; Li, QH; Lin, YN; Pang, TX; Wang, J; Wang, LH; Wang, RJ; Zhang, HJ | 1 |
He, L; Ji, BS; Liu, GQ | 1 |
Ackerley, C; Clarke, DM; De Rosa, MF; Ito, S; Lingwood, C; Wang, B | 1 |
Ambudkar, SV; Barnett, D; Bates, SE; Finley, EM; Fojo, T; Oldham, RK; Robey, RW; Shukla, S | 1 |
Avilés-Salas, A; Carreño-Fuentes, L; Gallardo-Pérez, JC; Maldonado-Lagunas, V; Marín-Hernández, A; Moreno-Sánchez, R; Rodríguez-Enríquez, S | 1 |
Bernal, SD; Chen, LB; Lampidis, TJ; Nadakavukaren, JJ; Nadakavukaren, KK; Shepherd, EL; Summerhayes, IC | 1 |
Chardonnet, Y; Chignol, MC; Lizard, G; Schmitt, D | 1 |
Carli, PM; Lizard, G; Maynadié, M; Parmeland, C; Solary, E | 1 |
Castro, DJ; Haghighat, S; Lufkin, R; Plant, D; Saxton, RE; Soudant, J | 1 |
Castro, DJ; Haghighat, S; Plant, D; Reisler, E; Saxton, RE; Soudant, J | 1 |
Freyer, JP; Habbersett, RC; Kunz-Schughart, LA | 1 |
Kessel, D | 1 |
Castro, DJ; Fetterman, HR; Haghighat, S; Lufkin, RB; Saxton, RE; Soudant, J; Ward, PH | 1 |
Kawasaki, M; Murakami, T; Ogino, T; Sasaki, K; Takahashi, M; Tanaka, K; Tenjin, T | 1 |
Chen, LB | 1 |
Dasdia, T; Fava, G; Marchesini, R; Melloni, E; Rocca, E; Zunino, F | 1 |
Benz, C; Hollander, C; James, TL; Keniry, M; Mitchell, M | 1 |
4 review(s) available for rhodamine 123 and Benign Neoplasms
Article | Year |
---|---|
From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.
Topics: Anthracyclines; Antineoplastic Agents; Cations; Cell Hypoxia; Deoxyglucose; Glycolysis; Humans; Hypoxia; Mitochondria; Neoplasms; Reference Values; Rhodamine 123 | 2009 |
Multidrug resistance through the spectacle of P-glycoprotein.
Topics: Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cloning, Molecular; Daunorubicin; Drug Resistance, Multiple; Genes, MDR; Humans; Kinetics; Models, Genetic; Neoplasms; Rhodamine 123 | 2009 |
Combination therapy involving photosensitizing agents.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Humans; Mammary Neoplasms, Experimental; Mice; Neoplasms; Radiation-Sensitizing Agents; Rhodamine 123; Rhodamines | 1992 |
Mitochondrial membrane potential in living cells.
Topics: Animals; Cell Differentiation; Cell Division; Cell Movement; Cells, Cultured; Energy Metabolism; Flow Cytometry; Humans; In Vitro Techniques; Intracellular Membranes; Membrane Potentials; Mitochondria; Neoplasms; Rhodamine 123; Rhodamines | 1988 |
1 trial(s) available for rhodamine 123 and Benign Neoplasms
Article | Year |
---|---|
Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
Topics: Adenosine Triphosphatases; Alkaloids; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Factors; Biological Transport; Cell Line; Cell Line, Tumor; Cyclosporins; Depsipeptides; Fluorescent Dyes; Fluorouracil; Humans; Insecta; Multidrug Resistance-Associated Proteins; Neoplasms; Paclitaxel; Prazosin; Quinolines; Rhodamine 123; Verapamil; Vinblastine | 2008 |
29 other study(ies) available for rhodamine 123 and Benign Neoplasms
Article | Year |
---|---|
Low-dose Pimecrolimus, an FDA-approved Calcineurin Inhibitor, Sensitizes Drug-resistant Cancer Cells
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcineurin Inhibitors; Cyclosporine; Humans; Neoplasms; Rhodamine 123; Tacrolimus | 2023 |
Comparison of Chemotherapeutic Activities of Rhodamine-Based GUMBOS and NanoGUMBOS.
Topics: Cell Line, Tumor; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Neoplasms; Organic Chemicals; Rhodamine 123; Rhodamines; Solubility; Water | 2020 |
Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cytoskeletal Proteins; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Genetic Vectors; Hep G2 Cells; Humans; Membrane Glycoproteins; Membrane Proteins; Microfilament Proteins; Neoplasms; Paclitaxel; Rhodamine 123; RNA, Messenger; RNA, Small Interfering; Snail Family Transcription Factors; Transfection | 2021 |
Mitochondria-Targeting Polydopamine Nanocomposites as Chemophotothermal Therapeutics for Cancer.
Topics: Animals; Doxorubicin; Drug Delivery Systems; Drug Synergism; Humans; Indoles; Infrared Rays; Mice; Mitochondria; Nanocomposites; Nanoparticles; Neoplasms; Photochemotherapy; Polymers; Rhodamine 123 | 2018 |
PCI29732, a Bruton's Tyrosine Kinase Inhibitor, Enhanced the Efficacy of Conventional Chemotherapeutic Agents in ABCG2-Overexpressing Cancer Cells.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cell Survival; Cyclopentanes; Doxorubicin; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Rhodamine 123 | 2018 |
Multifunctional nanoparticles based on a single-molecule modification for the treatment of drug-resistant cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorouracil; Humans; Hydrolysis; Models, Chemical; Nanoparticles; Neoplasms; Paclitaxel; Polyethylene Glycols; Rhodamine 123; Vitamin E | 2013 |
¹⁸FDG a PET tumor diagnostic tracer is not a substrate of the ABC transporter P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Mice; Neoplasms; NIH 3T3 Cells; Positron-Emission Tomography; Rhodamine 123; Substrate Specificity | 2014 |
[The study of mechanisms of accumulation of daunorubicin and rodamin-123 in cells of human venous blood using cytometry technique].
Topics: Blood Platelets; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Healthy Volunteers; Humans; Leukocytes; Neoplasms; Rhodamine 123 | 2015 |
Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.
Topics: Acetylation; Adenosine Triphosphatases; alpha-Cyclodextrins; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cytoskeleton; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Membrane Potential, Mitochondrial; Nanomedicine; Nanoparticles; Neoplasms; Paclitaxel; Rhodamine 123 | 2015 |
Response of heterogeneous cancer cells on targeted nanoparticles.
Topics: ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Nanoparticles; Neoplasms; Rhodamine 123 | 2016 |
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Western; Cell Line, Tumor; DNA Primers; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123 | 2008 |
A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging.
Topics: Acrylic Resins; Cell Death; Cell Line; Cell Survival; Elements; Ferric Compounds; Flow Cytometry; Fluorescent Dyes; Folic Acid; Humans; Magnetic Resonance Spectroscopy; Magnetics; Microscopy, Confocal; Molecular Imaging; Nanostructures; Neoplasms; Organ Specificity; Phantoms, Imaging; Polyethylene Glycols; Rhodamine 123; Temperature | 2010 |
Mitochondrial targeting for photochemotherapy. Can selective tumor cell killing be predicted based on n-octanol/water distribution coefficients?
Topics: Animals; Antineoplastic Agents; Cations; Coloring Agents; Drug Delivery Systems; Female; Haplorhini; Humans; Mitochondria; Neoplasms; Photochemotherapy; Rhodamine 123; Rhodamines; Rosaniline Dyes; Sensitivity and Specificity; Tumor Cells, Cultured | 2011 |
Highly biocompatible TiO₂:Gd³⁺ nano-contrast agent with enhanced longitudinal relaxivity for targeted cancer imaging.
Topics: Biocompatible Materials; Cell Line; Cell Membrane; Contrast Media; Cytokines; Gadolinium; Hemolysis; Humans; Magnetic Resonance Imaging; Metal Nanoparticles; Neoplasms; Platelet Aggregation; Radionuclide Imaging; Reactive Oxygen Species; Rhodamine 123; Titanium | 2011 |
Crizotinib (PF-02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P-glycoprotein.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Crizotinib; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Mice; Mice, Nude; Neoplasms; Paclitaxel; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Rhodamine 123; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Neutrophil gelatinase-associated lipocalin regulates intracellular accumulation of Rh123 in cancer cells.
Topics: Acute-Phase Proteins; Biological Transport; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Gene Knockdown Techniques; Humans; Lipocalin-2; Lipocalins; Neoplasms; Proto-Oncogene Proteins; Rhodamine 123 | 2012 |
Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
Topics: Amlodipine; Analysis of Variance; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Therapy; Flow Cytometry; Fluorescence; Humans; K562 Cells; Neoplasms; Rhodamine 123; Tetrazolium Salts; Thiazoles; Time Factors; Verapamil | 2005 |
Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
Topics: Adamantane; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Caco-2 Cells; Calcium Channel Blockers; Cell Membrane; Cell Polarity; Cyclosporine; Dogs; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Enzyme Inhibitors; Fluorescent Dyes; Golgi Apparatus; Humans; Intestinal Mucosa; Neoplasms; Protein Binding; Protein Structure, Secondary; Protein Synthesis Inhibitors; Protein Transport; Rhodamine 123; Shiga Toxins; Time Factors; Trihexosylceramides; Up-Regulation; Verapamil; Vinblastine | 2008 |
Energy metabolism transition in multi-cellular human tumor spheroids.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Deoxyglucose; Energy Metabolism; Fluorescent Dyes; Glycolysis; Gossypol; Humans; Lactones; Neoplasms; Organometallic Compounds; Oxidative Phosphorylation; Oxygen; Rhodamine 123; Spheroids, Cellular | 2008 |
Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Humans; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Mitochondria; Mitochondria, Muscle; Neoplasms; Rhodamine 123; Rhodamines; Xanthenes | 1982 |
Active cell membrane mechanisms involved in the exclusion of Rh 123 allow distinction between normal and tumoral cells.
Topics: Cell Membrane; Cells, Cultured; Drug Resistance, Multiple; Fibroblasts; Flow Cytometry; Humans; Neoplasms; Probenecid; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil | 1994 |
[Value of rhodamine 123 in the detection of minor amounts of multidrug resistant cells].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Drug Resistance, Multiple; Flow Cytometry; Humans; In Vitro Techniques; Neoplasms; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1994 |
Dose response of human tumor cells to rhodamine 123 and laser phototherapy.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Fibroblasts; Fibrosarcoma; Fluorescent Dyes; Humans; Laser Therapy; Melanoma; Mitochondria; Neoplasms; Photochemotherapy; Rhodamine 123; Rhodamines; Tetrazolium Salts; Tumor Cells, Cultured | 1994 |
The synergistic effects of rhodamine-123 and merocyanine-540 laser dyes on human tumor cell lines: a new approach to laser phototherapy.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Carcinoma, Squamous Cell; Cell Survival; Drug Synergism; Fluorescent Dyes; Hot Temperature; Humans; Laser Therapy; Leukemia, B-Cell; Leukemia, Erythroblastic, Acute; Lung Neoplasms; Melanoma; Neoplasms; Photochemotherapy; Photosensitizing Agents; Pyrimidinones; Radiation Dosage; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1993 |
Impact of proliferative activity and tumorigenic conversion on mitochondrial function of fibroblasts in 2D and 3D culture.
Topics: Acridine Orange; Animals; Benzimidazoles; Cell Culture Techniques; Cell Cycle; Cell Division; Cell Line, Transformed; Cell Size; Coloring Agents; DNA, Neoplasm; Fibroblasts; Fluorescent Dyes; Membrane Potentials; Mitochondria; Neoplasms; Rats; Rhodamine 123 | 2001 |
Laser dyes for experimental phototherapy of human cancer: comparison of three rhodamines.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Cell Division; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Radiation; Fluorescent Dyes; Hot Temperature; Humans; Laser Therapy; Medulloblastoma; Neoplasms; Photochemotherapy; Rhodamine 123; Rhodamines; Tumor Cells, Cultured | 1992 |
[Estimation of cell viability by FCM using rhodamin 123 and propidum iodide--its application in evaluating the effect of anticancer drugs to tumor cells].
Topics: Antineoplastic Agents; Cell Survival; Flow Cytometry; Humans; Neoplasms; Phenanthridines; Propidium; Rhodamine 123; Rhodamines; Staining and Labeling; Xanthenes | 1988 |
In vitro photosensitizing properties of rhodamine 123 on different human tumor cell lines.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Drug Screening Assays, Antitumor; Humans; Light; Neoplasms; Radiation-Sensitizing Agents; Rhodamine 123; Rhodamines; Xanthenes | 1988 |
Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.
Topics: Cell Division; Cell Line; Cell Survival; Colony-Forming Units Assay; Female; Gossypol; Hematopoietic Stem Cells; Humans; Isoenzymes; L-Lactate Dehydrogenase; Magnetic Resonance Spectroscopy; Male; Neoplasms; Phosphorus; Rhodamine 123; Rhodamines; Tumor Stem Cell Assay; Xanthenes | 1987 |